219 related articles for article (PubMed ID: 25120951)
1. Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.
Raval M; Bande D; Pillai AK; Blaszkowsky LS; Ganguli S; Beg MS; Kalva SP
Front Oncol; 2014; 4():120. PubMed ID: 25120951
[TBL] [Abstract][Full Text] [Related]
2. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
[TBL] [Abstract][Full Text] [Related]
3. Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology.
Lu S; Dhillon J; Johnson JH; El-Haddad G
EJNMMI Res; 2021 Feb; 11(1):17. PubMed ID: 33604708
[TBL] [Abstract][Full Text] [Related]
4. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA;
BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708
[TBL] [Abstract][Full Text] [Related]
5. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review.
Baltatzis M; Siriwardena AK
Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488
[TBL] [Abstract][Full Text] [Related]
6. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ
World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957
[TBL] [Abstract][Full Text] [Related]
7. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
Kuei A; Saab S; Cho SK; Kee ST; Lee EW
World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
[TBL] [Abstract][Full Text] [Related]
8. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
Wang DS; Louie JD; Sze DY
Tech Vasc Interv Radiol; 2019 Jun; 22(2):74-80. PubMed ID: 31079714
[TBL] [Abstract][Full Text] [Related]
9. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
[TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma.
Makary MS; Krishner LS; Wuthrick EJ; Bloomston MP; Dowell JD
World J Clin Oncol; 2018 Feb; 9(1):20-25. PubMed ID: 29468134
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.
Kennedy AS; Ball D; Cohen SJ; Cohn M; Coldwell DM; Drooz A; Ehrenwald E; Kanani S; Rose SC; Nutting CW; Moeslein FM; Savin MA; Schirm S; Putnam SG; Sharma NK; Wang EA
J Gastrointest Oncol; 2015 Apr; 6(2):134-42. PubMed ID: 25830033
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP
J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573
[TBL] [Abstract][Full Text] [Related]
14. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
Boas FE; Bodei L; Sofocleous CT
J Nucl Med; 2017 Sep; 58(Suppl 2):104S-111S. PubMed ID: 28864605
[TBL] [Abstract][Full Text] [Related]
16. Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.
Jeyarajah DR; Doyle MBM; Espat NJ; Hansen PD; Iannitti DA; Kim J; Thambi-Pillai T; Visser BC
J Gastrointest Oncol; 2020 Apr; 11(2):443-460. PubMed ID: 32399284
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?
Sangha BS; Nimeiri H; Hickey R; Salem R; Lewandowski RJ
Curr Treat Options Oncol; 2016 Jun; 17(6):26. PubMed ID: 27098532
[TBL] [Abstract][Full Text] [Related]
18. Administered activity and outcomes of glass versus resin (90)Y microsphere radioembolization in patients with colorectal liver metastases.
Srinivas SM; Nasr EC; Kunam VK; Bullen JA; Purysko AS
J Gastrointest Oncol; 2016 Aug; 7(4):530-9. PubMed ID: 27563442
[TBL] [Abstract][Full Text] [Related]
19. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
Xing M; Prajapati HJ; Dhanasekaran R; Lawson DH; Kokabi N; Eaton BR; Kim HS
Am J Clin Oncol; 2017 Feb; 40(1):27-34. PubMed ID: 25089529
[TBL] [Abstract][Full Text] [Related]
20. Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases.
O'Leary C; Greally M; McCaffrey J; Hughes P; Lawler LLP; O'Connell M; Geoghegan T; Farrelly C
Ir J Med Sci; 2019 Feb; 188(1):43-53. PubMed ID: 29511912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]